Free Submission Public Relations &
Deutsch English


New Report Available: Ragweed Allergy - Pipeline Review, H2 2013

Print article Print article
2013-12-22 01:50:36 - Fast Market Research recommends "Ragweed Allergy - Pipeline Review, H2 2013" from Global Markets Direct, now available

Global Markets Direct's, 'Ragweed Allergy - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Ragweed Allergy, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Ragweed Allergy. Ragweed Allergy - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

Full Report Details at
- ..

Note*: Certain sections in the report may be removed or altered based on the availability and

relevance of data for the indicated disease.


* A snapshot of the global therapeutic scenario for Ragweed Allergy.
* A review of the Ragweed Allergy products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
* Coverage of products based on various stages of development ranging from discovery till registration stages.
* A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
* Coverage of the Ragweed Allergy pipeline on the basis of route of administration and molecule type.
* Key discontinued pipeline projects.
* Latest news and deals relating to the products.

Reasons to Get this Report

* Identify and understand important and diverse types of therapeutics under development for Ragweed Allergy.
* Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
* Plan mergers and acquisitions effectively by identifying players of the most promising pipeline.
* Devise corrective measures for pipeline projects by understanding Ragweed Allergy pipeline depth and focus of Indication therapeutics.
* Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
* Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.

Companies Mentioned in this Report: ALK-Abello A/S, Allergy Therapeutics plc, Stallergenes S.A., Circassia Holdings Ltd., ANERGIS SA, Immunomic Therapeutics, Inc., Biomay AG

Partial Table of Contents:

Table of Contents
Table of Contents
List of Tables
List of Figures
Global Markets Direct Report Coverage
Ragweed Allergy Overview
Therapeutics Development
An Overview of Pipeline Products for Ragweed Allergy
Ragweed Allergy Therapeutics under Development by Companies
Late Stage Products
Comparative Analysis
Mid Clinical Stage Products
Comparative Analysis
Early Clinical Stage Products
Comparative Analysis
Discovery and Pre-Clinical Stage Products
Comparative Analysis
Ragweed Allergy Therapeutics - Products under Development by Companies
Companies Involved in Ragweed Allergy Therapeutics Development
ALK-Abello A/S
Allergy Therapeutics plc
Stallergenes S.A.
Circassia Holdings Ltd.
Immunomic Therapeutics, Inc.
Biomay AG
Ragweed Allergy - Therapeutics Assessment
Assessment by Monotherapy Products
Assessment by Route of Administration
Assessment by Molecule Type
Drug Profiles
Pollinex Ragweed - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Ragweed-SPIRE - Drug Profile
Product Description
Mechanism of Action
R&D Progress
MK-3641 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Ragweed Pollen Allergen Extract - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Ragweed Hypoallergenic Vaccine For - Drug Profile
Product Description
Mechanism of Action
R&D Progress
MULTI-LAMP-Vax - Drug Profile
Product Description
Mechanism of Action
R&D Progress
AllerR - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Ragweed Allergen Peptide Carrier Fusion Vaccine - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Ragweed Allergy Therapeutics - Drug Profile Updates
Ragweed Allergy Therapeutics - Discontinued Products
Ragweed Allergy Therapeutics - Dormant Products
Ragweed Allergy - Product Development Milestones
Featured News & Press Releases
May 08, 2013: Merck Announces FDA Acceptance Of Biologics License Application For Investigational Ragweed Pollen Sublingual Allergy Immunotherapy Tablet
Mar 11, 2013: ALK's Partner Merck Submits BLA To FDA For Marketing Authorization For Ragweed AIT
Feb 25, 2013: Greer Labs Announces Presentation Of New Data From Phase III Trial Evaluating Sublingual Immunotherapy For Short Ragweed Allergies At Allergy Meeting
Feb 22, 2013: Merck To Present New Data Analyses Of Its Investigational Ragweed Pollen And Grass Pollen Allergy Immunotherapy Tablets At 2013 AAAAI Annual Meeting
Feb 21, 2013: Anergis To Present Preclinical Data On Ragweed Allergy Vaccine Candidate AllerR At AAAAI 2013 Annual Meeting
Jun 14, 2012: Anergis Reaches Several Preclinical Development Milestones With Ragweed Pollen Vaccine
Jun 12, 2012: GREER Reports Positive Findings From Phase III Trial Evaluating Sublingual Immunotherapy For Ragweed Allergies
Mar 07, 2012: Circassia's Ragweed Allergy Therapy Achieves Positive Phase II Clinical Results
Jan 19, 2012: Circassia Receives European Patent For Its Ragweed Allergy T-Cell Vaccine
Secondary Research
Primary Research
Expert Panel Validation
Contact Us

Full Table of Contents is available at:

About Global Markets Direct

Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information. View more research from Global Markets Direct at

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at or call us at 1.800.844.8156.

Bill Thompson
Phone: 18008448156

Disclaimer: If you have any questions regarding information in these press releases please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims contents contained in this release.
Latest News
Read the Latest News


Terms & Conditions | Privacy | About us | Contact | BidVertiser